Skip to main content

Table 3 The rate of adverse effects by the groups

From: Randomized controlled clinical trial comparing the efficacy and tolerability of aripiprazole and sodium valproate in the treatment of Tourette syndrome

 

Time (days)

Sodium valproate (n = 12)

Aripiprazole (n = 12)

Z

p

CGI-I

5

1.00 (1.00, 2.00)

2.00 (2.00, 3.00)

− 2.705

0.008

10

1.00 (1.00, 1.00)

2.00 (2.00, 2.00)

− 3.104

0.004

TESS

5

0.00 (0.00, 1.00)

0.00 (0.00, 1.00)

− 0.173

0.887

10

1.00 (0.25, 1.75)

1.00 (0.25, 1.00)

− 0.619

0.590

Back to article page

Annals of General Psychiatry

ISSN: 1744-859X